Nebraska Oncology Society

Nebraska Oncology Society is a non-profit organization that has been in existence since 1992. Our mission is to facilitate and promote interaction among the oncology community to enhance patient care through oncology research, education, and health care legislation.

https://www.nebraskaoncology.org/

 

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review
34:39

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Genomic/Molecular Profiling & Targeting Adaptive Resistance in BC: Replication Stress & PARPi, (K)RAS Mutations, Adaptive Multi-Drug Treatment, Olaparib Mono

FEATURING Gordon Mills
  • 122 views
  • February 26, 2021
45:55

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Axilla Management Updates: Omitting SLND, cN- (SLN+ & Elderly Patients), cN+ (Clipped Nodes, Outcomes With Omission of ALND), Impact of RxPonder

FEATURING Abigail Caudle
  • 200 views
  • February 26, 2021
27:54

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Updates on Adjuvant ET in ER+ BC: How Do Genomic Studies Guide ET Decision Choice? Is Abemaciclib+ET Effective in HR+/HER2- High-Risk EBC?

FEATURING Bora Lim
  • 371 views
  • February 26, 2021
  • 4
06:43

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Advanced ER+ BC Highlights: Outcomes With Exemestane+/-Entinostat for Postmenopausal Women, Considering Tesetaxel+Capecitabine vs. Capecitabine Alone for HR+/HER2- mBC

FEATURING Bora Lim
  • 100 views
  • February 26, 2021
50:53

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Fertility Preservation in Women With BC: Basic Principles & Science Behind Oncofertility, Impact on Young BC Survivors, Options for Complex Patients

FEATURING Abigail Delaney
  • 120 views
  • February 26, 2021
08:57

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS ASCENT Trial Update on mTNBC: Is Sacituzumab Govitecan More Effective Over SoC Chemo in R/R Disease?

FEATURING Ingrid Mayer
  • 111 views
  • February 23, 2021
08:07

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

Novel Therapeutics in Advanced HER2+ MBC

FEATURING Ingrid Mayer
  • 42 views
  • February 23, 2021
10:21

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

ADCs in HER2+ MBC: Durable Antitumor Activity of T-DXd in a Pretreated Patient Population

FEATURING Ingrid Mayer
  • 183 views
  • February 23, 2021
  • 1
09:24

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Update on HER2+ MBC: How Effective Is Margetuximab + Chemo After Prior Anti-HER2 Therapies? What Are the Available Management Options for 1L and Beyond?

FEATURING Ingrid Mayer
  • 99 views
  • February 23, 2021
  • 1
14:16

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

SABCS Clinical Trial Data on IO in mTNBC: Do 1L Atezo or Pembro Added to Chemo Help Patients With PD-L1 Expression? Does Backbone Matter?

FEATURING Ingrid Mayer
  • 27 views
  • February 23, 2021